Doctors have watched patients experience cardiovascular events for years despite hitting their target LDL numbers, which prompted researchers to investigate remaining risk factors.
Analysis of 35,000 Blood Samples Connects Proteins to Inflammation
The research team examined roughly 3,000 proteins in blood samples taken from about 35,000 participants in the UK Biobank project. None of the participants had heart disease when the study began. The results show that two other types of fat-carrying particles in the blood—triglyceride-rich lipoproteins, known as TRL, and lipoprotein(a), known as Lp(a)—play a larger role in raising heart disease risks than doctors previously understood.
Identifying Pathways to Build Preventive Strategies
The lead researcher stated that these particles do more than deposit cholesterol inside artery walls. They also connect to protein patterns that signal inflammatory responses and blood vessel changes, which help drive the disease forward. The researcher explained that TRL and Lp(a) particles affect the same biological and inflammatory pathways, opening the door to a deeper understanding of persistent heart risks.
Identifying these mechanisms will help scientists build more precise preventive strategies that target risk factors which standard LDL-lowering treatments miss.
Frequently Asked Questions About Residual Heart Risks
What are triglyceride-rich lipoproteins and Lp(a)?
They are specialized fat-carrying particles in the blood that transport lipids through the circulatory system.
Why do patients with normal LDL levels still experience heart attacks?
While low-density lipoprotein remains a primary driver of coronary artery disease, researchers found that alternative biological pathways involving inflammation and lipid transport via TRL and Lp(a) particles continue to damage blood vessels even when primary cholesterol targets are met.
Researchers analyzed approximately 3,000 proteins across blood samples gathered from roughly 35,000 UK Biobank participants who were free of heart disease at the start of the project.